Naba Alsaha Medical Services Company
TADAWUL:9546.SR
88.8 (SAR) • At close September 19, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) SAR.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| 24.613 | 12.307 | 27.769 | 13.885 | 11.53 | 5.765 | 15.393 | 7.696 | 11.595 | 5.798 | 14.232 | 7.116 |
| Afschrijvingen & Amortisatie
| 4.689 | 2.288 | 4.805 | 2.345 | 3.465 | 1.702 | 3.3 | 1.65 | 3.226 | 1.613 | 2.897 | 1.448 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -14.508 | -16.872 | -11.53 | -3.912 | 2.76 | 3.034 | -5.487 | -2.911 | -9.084 | -4.882 | 4.7 | 2.316 |
| Vorderingen
| -34.622 | -16.258 | -16.882 | -8.441 | 5.832 | 2.989 | -4.155 | -2.077 | -4.868 | -2.434 | 3.741 | 1.87 |
| Voorraden
| -2.714 | -1.357 | -1.776 | -0.888 | 1.644 | 0.822 | -1.381 | -0.69 | 0.047 | 0.024 | -0.833 | -0.417 |
| Crediteuren
| 20.136 | 0 | -2.986 | 0 | -2.797 | 0 | 0.717 | 0 | 0.829 | 0 | 1.593 | 0 |
| Overig Werkkapitaal
| 2.692 | 0.743 | 10.114 | 5.417 | -1.919 | -0.778 | -0.668 | -0.143 | -5.091 | -2.472 | 0.2 | 0.862 |
| Overige Niet-Contante Posten
| 28.633 | 10.701 | 22.721 | -6.062 | 6.491 | 0.497 | 11.717 | 0.317 | 13.382 | 1.809 | 1.527 | 0.151 |
| Kasstroom uit Operationele Activiteiten
| 16.848 | 8.424 | 12.51 | 6.255 | 21.995 | 10.998 | 13.505 | 6.753 | 8.676 | 4.338 | 22.063 | 11.031 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -35.808 | -16.68 | -5.696 | -2.753 | -8.501 | -2.498 | -2.552 | -1.276 | -5.438 | -2.719 | -4.926 | -2.463 |
| Netto Overnames
| -1.132 | -0.566 | -16.978 | -8.489 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -1 | 0 | 0 | 0 | 0 | 0 | -2.829 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| -1.724 | -1.724 | -0.096 | -0.096 | -1.752 | -1.752 | -1.415 | -1.415 | 0 | 0 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| -37.94 | -18.97 | -22.674 | -11.337 | -8.501 | -4.251 | -5.382 | -2.691 | -5.438 | -2.719 | -4.926 | -2.463 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| -28.563 | 0 | -1.5 | 0 | -5 | 0 | -6 | 0 | -7.18 | 0 | -6.3 | 0 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -2.1 | -1.05 | 0 | 0 | -2.1 | -1.05 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| -7.475 | 10.071 | 7.475 | 2.566 | -2.921 | -2.921 | -3.421 | -3.421 | -3.972 | -3.972 | -3.611 | -3.611 |
| Kasstroom uit Financieringsactiviteiten
| 18.042 | 9.021 | 5.133 | 2.566 | -7.943 | -3.971 | -6.843 | -3.421 | -7.943 | -3.972 | -7.222 | -3.611 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | -11.051 | 6.994 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -3.05 | -1.525 | -5.031 | -2.516 | 5.552 | -8.275 | 1.281 | 0.64 | -4.706 | -2.353 | 9.914 | 4.957 |
| Kaspositie aan het Einde van de Periode
| 5.746 | -1.525 | 8.795 | -2.516 | 13.826 | 0 | 8.275 | 0.64 | 6.994 | 9.347 | 11.7 | 4.957 |